Goal 3: Advance Translational Research
Benefits of Antibiotics in COPD Exacerbations
What are the comparative benefits of oral corticosteroids and antibiotics versus oral corticosteroids alone for outpatient COPD exacerbation?
Goal 3: Advance Translational Research
What are the comparative benefits of oral corticosteroids and antibiotics versus oral corticosteroids alone for outpatient COPD exacerbation?
Goal 3: Advance Translational Research
How might NHLBI assist its awardees to attract private sector funding or partnerships earlier in the product development process to help bridge the gap between academic discoveries and product commercialization?
What molecular and cellular pathways explain the sex-specific differences in the prevalence, severity, and progression of lung diseases?
Goal 3: Advance Translational Research
Goal 3: Advance Translational Research
There needs to be development of integrated research teams that include clinicians, scientists, engineers, etc.
Goal 4: Develop Workforce and Resources
How can we provide better support for junior investigators who are transitioning from K Award to R Award funding?
Goal 3: Advance Translational Research
Can novel extracorporeal devices that remove carbon dioxide be tested to limit or avoid positive pressure ventilation in patients with acute respiratory failure from COPD?
As the current chair of the Research and Training Division, I would like to convey that the AAAAI membership would like the NHLBI to consider the following in the development of its strategic plan:
Will integration of behavior science in clinical research improve effectiveness of interventions for asthma associated with behavioral risk factors?
Goal 3: Advance Translational Research
Clinical trials are at a crossroads. They are too expensive, take too long, and often can't recruit adequately. A critical challenge is to develop tools that can change the cost, time, and recruiting practices for clinical trials.
Goal 3: Advance Translational Research
How can NHLBI harness the power of novel technologies involving nucleic acid delivery and gene editing for clinical therapeutics?